Table 1 Descriptive characteristics of the entire cohort (N = 1812)d.
From: Diagnosing hereditary cancer predisposition in men with prostate cancer
Total (N) | Total (%) | |
|---|---|---|
Age at testing (IQR) | 66 (59,73) | |
Race/ethnicity | ||
African American/Black | 109 | 6.0% |
Ashkenazi Jewish | 165 | 9.1% |
Asian | 23 | 1.3% |
Caucasian | 1268 | 70.0% |
Hispanic | 47 | 2.6% |
Middle Eastern | 7 | 0.4% |
Mixed ethnicity | 65 | 3.6% |
Native American | 2 | 0.1% |
Other | 8 | 0.4% |
Unknown | 118 | 6.5% |
Personal history of other cancersa | ||
Yes | 758 | 41.8% |
No | 1054 | 58.2% |
Personal history of other cancersc | ||
Breast | 105 | 5.8% |
Colorectal | 201 | 11.1% |
Pancreatic | 111 | 6.1% |
Other | 487 | 26.9% |
None | 1054 | 58.2% |
Family history of cancerb,c | ||
Yes | 1674 | 92.4% |
No | 138 | 7.6% |
Family history of cancer | ||
Breast | 943 | 52.0% |
Colorectal | 578 | 31.9% |
Pancreatic | 313 | 17.3% |
Prostate | 917 | 50.6% |
Other | 1177 | 65.0% |
Gleason score | ||
Low (<7) | 162 | 17.7% |
Intermediate (7) | 396 | 43.2% |
High (8–10) | 359 | 39.1% |
Missing | 895 | |
>1 Family member with breast, ovarian, or pancreatic cancer | ||
Yes | 649 | 35.8% |
No | 1163 | 64.2% |
>1 Family member with Lynch syndrome–related cancer | ||
Yes | 572 | 31.6% |
No | 1240 | 68.4% |
Test ordered | ||
ProstateNext | 284 | 15.7% |
Other multigene panel tests | 1528 | 84.3% |
